to main content Joint Commission International completes pilot using new technology during accreditation survey at Dubai hospital | Joint Commission International

Joint Commission International completes pilot using new technology during accreditation survey at Dubai hospital

8 April 2022

Media Contact:
Maureen Lyons
Corporate Communications 
(630) 792-5171

(OAK BROOK, Illinois, USA, 8 April 2022) – Joint Commission International (JCI) today announced it has successfully completed a pilot using innovative technology during an accreditation survey at Medcare Women & Children Hospital in Dubai, United Arab Emirates (UAE). Microsoft’s HoloLens (mixed-reality smart glasses) were operated during a hybrid survey from February 13-16, 2022.

During the survey, an on-site surveyor wore the HoloLens during specified tracers while JCI staff remotely observed the lens’ function through the surveyor. Tracer methodology, a key tool of JCI’s survey process, uses information from a healthcare organization to follow its experience of care, treatment or services for a number of patients throughout their entire healthcare delivery process. Information collected allows surveyors to review applicable standard requirements. 

“The pilot supports Joint Commission International’s efforts to drive healthcare organizations toward transforming and leveraging technology in different ways to reach patients around the world and improve patient safety and quality of care for them,” says Joel Roos, MD, MBA, MHCDS, CPE, vice president of International Accreditation, Quality Improvement and Safety, JCI. “It also supports our commitment to exploring opportunities to connect with and support our accredited organizations through innovative technologies – improving operational effectiveness and allowing for more continuous and robust engagement. JCI thanks Medcare Women & Children Hospital for allowing us to leverage the HoloLens technology during its survey.”

Hospital staff reported being comfortable with the HoloLens technology during survey and found the pilot to be an interesting experience. Additionally, the technology did not impede any tracer activity. 

JCI is examining outcomes of the pilot to use in future testing and exploration of how the HoloLens and similar technology can enhance client engagement throughout the accreditation cycle and beyond.


About Joint Commission International 
Joint Commission International (JCI) was established in 1994 as a division of Joint Commission Resources, Inc. (JCR), a wholly controlled, nonprofit affiliate of The Joint Commission. Through international accreditation and certification, advisory services, publications and education programs, JCI extends The Joint Commission’s mission worldwide by helping improve the quality of patient care. JCI works with international healthcare organizations, public health agencies, health ministries and others in more than 70 countries. Visit for more information.